BioCentury | Dec 21, 2009
Finance

Ebb & Flow

The 2004 merger of Fujisawa Pharmaceutical Co. Ltd. and Yamanouchi Pharmaceutical Co. Ltd. to form Astellas Pharma Inc . (Tokyo:4503) has led to big payoffs in the last two weeks for Calixa Therapeutics Inc. and Gloucester...
BioCentury | Oct 27, 2003
Finance

Ebb & Flow

...patterns for minimally invasive diagnosis, clinical management of patients and drug development. Hoosier Daddy? The Indiana Future Fund I...
BioCentury | Oct 21, 2003
Financial News

Indiana raises $72 million VC fund

...The Indiana Future Fund I raised $72 million for its fund-of-funds life science investment initiative. The fund plans to...
Items per page:
1 - 3 of 3
BioCentury | Dec 21, 2009
Finance

Ebb & Flow

The 2004 merger of Fujisawa Pharmaceutical Co. Ltd. and Yamanouchi Pharmaceutical Co. Ltd. to form Astellas Pharma Inc . (Tokyo:4503) has led to big payoffs in the last two weeks for Calixa Therapeutics Inc. and Gloucester...
BioCentury | Oct 27, 2003
Finance

Ebb & Flow

...patterns for minimally invasive diagnosis, clinical management of patients and drug development. Hoosier Daddy? The Indiana Future Fund I...
BioCentury | Oct 21, 2003
Financial News

Indiana raises $72 million VC fund

...The Indiana Future Fund I raised $72 million for its fund-of-funds life science investment initiative. The fund plans to...
Items per page:
1 - 3 of 3